New keytruda copycat tested in lung cancer patients
NCT ID NCT06268613
First seen Nov 01, 2025 · Last updated May 07, 2026 · Updated 30 times
Summary
This study compares a new drug, SB27, to the approved cancer medicine Keytruda in people with early-stage non-small cell lung cancer who have already had surgery and chemotherapy. The main goal is to see if SB27 stays in the body the same way as Keytruda. About 163 adults will receive one of the three treatments every three weeks for up to 18 cycles.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER STAGE II are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
SB Investigative Site
Gdansk, Poland
-
SB Investigative Site
Otwock, Poland
-
SB Investigative Site
Ansan, South Korea
-
SB Investigative Site
Busan, South Korea
-
SB Investigative Site
Daegu, South Korea
-
SB Investigative Site
Hwasun, South Korea
-
SB Investigative Site
Incheon, South Korea
-
SB Investigative Site
Jinju, South Korea
-
SB Investigative Site
Seongnam, South Korea
-
SB Investigative Site
Ulsan, South Korea
-
SB Investigative Site
Jaén, Jaén, Spain
-
SB Investigative Site
A Coruña, Santiago de Compostela, Spain
-
SB Investigative Site
Málaga, Spain
-
SB Investigative Site
Adana, Turkey (Türkiye)
-
SB Investigative Site
Istanbul, Turkey (Türkiye)
-
SB Investigative Site
Izmir, Turkey (Türkiye)
-
SB Investigative Site 1
Suwon, South Korea
-
SB Investigative Site 1
Ankara, Turkey (Türkiye)
-
SB Investigative Site 2
Suwon, South Korea
-
SB Investigative Site 2
Ankara, Turkey (Türkiye)
-
SB Investigative Site 3
Seoul, South Korea
-
SB Investigative Site 4
Seoul, South Korea
-
SB Investigative Site 5
Seoul, South Korea
-
SB Investigative Site 6
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.